Drugs / [177Lu]Lu-PSMA-137
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06546527 | Aug 2024 → Mar 2025 overdue | prostate cancer | Peking University First Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [177Lu]Lu-PSMA-137 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06546527 ↗ |